WHO rules call for manufacturers to put into action a continuous danger administration approach for sterility test isolators, such as common possibility assessments and the development of threat-based Management procedures. The risk management procedure begins with a radical Investigation of prospective failure modes and their likely impacts on sterility waiting for link from Forum Profiles (6)